Arlo

Here is a fact that health insurance would prefer you not dwell on: for a long stretch of the industry's history, the reliable way to make a plan cheaper was to make care harder to get. Deny the claim, narrow the network, bury the approval in a phone tree. It works, in the narrow accounting sense that most bad ideas work.

Arlo, a New York startup founded in 2022, is a bet that you can do the opposite and still come out ahead. The company sells level-funded, self-funded health plans to small and mid-sized businesses - roughly the 10-to-150-employee range that is too big to ignore benefits and too small to negotiate good ones. Its pitch is that if you underwrite risk with machine learning and pay providers to keep people healthy rather than to run up bills, the math actually closes. Preventive care becomes the cheapest line item, not a cost center.

The people making this argument are not career insurance executives, which is either a feature or a bug depending on your priors. Co-founder and CEO Jan-Felix Schneider grew up in Germany and spent years at Palantir Technologies as a team lead, working with insurers on value-based care and claims data. That is a useful place to have stood: close enough to the industry to know where the money leaks, far enough outside it to be annoyed by the leaking. Co-founder and CTO Karthik Bhaskara previously led engineering at Finch. Between them, the founding instinct was less "let's start an insurance company" and more "let's rebuild this thing the way engineers would."

What that looks like in practice is an underwriting engine that assesses health risk with data models instead of the slow, manual, large-group-favoring process that small employers usually get stuck with. Automate the underwriting, and a 40-person company can be priced with something closer to the sophistication a 4,000-person company enjoys. That is the core trick, and everything else - the app, the $0 copays, the transparency tools - hangs off it.

The incentive point is worth sitting with, because it is the whole thesis in one sentence. In a conventional plan, nobody in the chain is especially rewarded for you catching a problem early. In Arlo's telling, aligning employers, employees, and providers around preventive care produces "both immediate savings and long-term stability" - the rare arrangement where the cheap thing and the good thing are the same thing. Hence the $0 primary-care copays and covered screenings: Arlo would rather pay for the checkup that catches the issue than the emergency that follows from missing it. This is not charity. It is arithmetic dressed up as decency, which is the best kind.

The member-facing side is an app that behaves like a piece of consumer software rather than an insurance portal. It decodes benefits, estimates what care will cost before you book it, points you to the right in-network provider, and - the part that keeps it honest - loops in human clinicians. Arlo describes an AI care guide in the mix. The ambition is coverage, navigation, and payment working as one system instead of three adversaries.

None of this would matter if the numbers were vaporware, and here Arlo's story is unusually concrete for a seed-stage company. In its first year it wrote mid-eight-figures in premiums. It signed more than 200 small and mid-sized businesses. And - the detail that makes insurtech investors sit up - it reached profitability in under two years, a sentence rarely spoken about companies this young. In March 2025 it raised a $4 million seed round led by Upfront Ventures, with 8VC and General Catalyst along for it.

The risk plumbing is handled by a name older than every founder in the building: Nationwide reinsures Arlo's stop-loss, with Arlo acting as the managing general underwriter. It is a tidy arrangement - a legacy balance sheet absorbing the tail risk while a software-first team handles the pricing, the product, and the member experience. Distribution runs the traditional way, through brokers and benefits firms, because even a company trying to disrupt insurance still has to sell it where insurance gets sold.

What Arlo is really selling to a founder or an office manager is the removal of a headache they never asked to own. Big-company benefits, the promise goes, without big-company administration. Whether it scales to its stated goal - one million lives covered within five years - is the open question, and it is a genuinely open one. But the early evidence suggests the incentive-alignment argument is not only a nice slide. It is, so far, a working business.